Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
Sell
-1,380
Closed -$227K 102
2025
Q1
$227K Hold
1,380
0.26% 96
2024
Q4
$225K Buy
+1,380
New +$247K 0.2% 99
2023
Q4
Sell
-5,387
Closed -$937K 116
2023
Q3
$937K Buy
5,387
+104
+2% +$18.9K 0.93% 46
2023
Q2
$910K Sell
5,283
-160
-3% -$27.7K 0.81% 62
2023
Q1
$893K Buy
+5,443
New +$892K 0.82% 64
2022
Q3
Sell
-2,052
Closed -$353K 108
2022
Q2
$353K Sell
2,052
-330
-14% -$57.1K 0.25% 108
2022
Q1
$449K Sell
2,382
-132
-5% -$26.1K 0.2% 107
2021
Q4
$613K Buy
2,514
+493
+24% +$108K 0.22% 107
2021
Q3
$392K Sell
2,021
-4,224
-68% -$852K 0.18% 82
2021
Q2
$1.16M Sell
6,245
-715
-10% -$124K 0.4% 87
2021
Q1
$1.1M Sell
6,960
-3,258
-32% -$516K 0.39% 93
2020
Q4
$1.68M Buy
+10,218
New +$1.66M 0.83% 66

Other funds holding ZTS

SRN Advisors's ZTS Position: Q2 2025 in Review

SRN Advisors sold out of Zoetis (ZTS) in Q2 2025, closing a stake of 1,380 shares — an estimated $227K sold.

SRN Advisors first reported a position in ZTS in Q4 2020 and held it in 12 quarters. The position peaked at $1.68M in Q4 2020. 1,870 funds tracked by Wall St. Rank hold ZTS as of Q2 2025.

  • SRN Advisors reported no remaining Zoetis position as of Q2 2025 after selling out during the quarter.
  • SRN Advisors sold 1,380 Zoetis shares in Q2 2025, an estimated $227K.
  • SRN Advisors first reported a position in Zoetis in Q4 2020 and held it in 12 quarters.
  • SRN Advisors's Zoetis position peaked at $1.68M in Q4 2020.
  • 1,870 funds tracked by Wall St. Rank held Zoetis as of Q2 2025.

Based on SRN Advisors's 13F filing for Q2 2025, filed 14 Aug 2025.